Clinical Trials Directory

Trials / Unknown

UnknownNCT03496753

Effect of LED Therapy for Treatment Nipple Fissure

Effect of LED Therapy for the Treatment Nipple Fissures: a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University of Nove de Julho · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Treatment options for nipple fissures include drug therapy with antifungal and antibiotics, topical applications of lanolin, glycerin gel, creams and lotions, the milk itself, hot compresses and silicone nipple shields. Studies involving a light-emitting diode (LED) therapy have demonstrated anti-inflammatory properties, the enhancement of the wound repair process and the control of pain.

Detailed description

Nipple fissures are the second major cause of the discontinuation of breastfeeding, following a sensation of insufficient milk, which leads to bottle feeding. Poor positioning of the child in relation to the breast, an inadequate frequency or duration of breastfeeding and improper suckling are the main causes of nipple fissure. Discontinuing breastfeeding deprives the infant of essential nutrients and also deprives the mother of certain health benefits. Treatment options for nipple fissures include drug therapy with antifungal and antibiotics, topical applications of lanolin, glycerin gel, creams and lotions, the milk itself, hot compresses and silicone nipple shields. Studies involving a light-emitting diode (LED) therapy have demonstrated anti-inflammatory properties, the enhancement of the wound repair process and the control of pain. As it does not cause discomfort, is relatively inexpensive and may impede the discontinuation of breastfeeding, phototherapy could be a viable option for the treatment of nipple fissures. The aim of this study is to evaluate LED therapy in treatment of nipple fissures

Conditions

Interventions

TypeNameDescription
DEVICELed TherapyThe following will be the phototherapeutic parameters: total spot area: 1.44 cm²; continuous emission mode; output power: 10 mW; infrared wavelength (880 to 904 nm); fluence: 4 J/cm²; and application time: 10 minutes/session. Sessions will be held three times a week on alternating days for six consecutive weeks, totaling 18 sessions.

Timeline

Start date
2018-08-20
Primary completion
2018-09-20
Completion
2019-08-20
First posted
2018-04-12
Last updated
2018-04-12

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03496753. Inclusion in this directory is not an endorsement.